Bio-Rad Laboratories Class B
BIO.B
6 hedge funds and large institutions have $9.14M invested in Bio-Rad Laboratories Class B in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
15% more capital invested
Capital invested by funds: $7.92M → $9.14M (+$1.22M)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more ownership
Funds ownership: 0.62% → 0.62% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$27.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$826 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $6.39M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $1.9M | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $420K | -$826 | -3 | -0.2% |
|
4
Renaissance Technologies
New York
| $314K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $106K | +$27.5K | +100 | +37% |
|
6
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
BIO.B Hedge Fund Activity: Q2 2018 in Review
6 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2018, worth a combined $9.14M — up 15% from $7.92M a quarter earlier.
Fund positioning in BIO.B was balanced in Q2 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $27.5K. The largest seller was Susquehanna International Group, cutting an estimated $826.
- 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $9.14M of Bio-Rad Laboratories Class B stock for Q2 2018, up 15% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q2 2018 and 0 closed out.
- The largest Bio-Rad Laboratories Class B buyer in Q2 2018 was UBS Group, an estimated $27.5K added.
- The largest Bio-Rad Laboratories Class B seller in Q2 2018 was Susquehanna International Group, an estimated $826 sold.
Based on aggregated 13F filings for Q2 2018.